Clinical research programs operate in an increasingly competitive environment. Sponsors expect sites to activate studies more quickly, enroll participants more efficiently, and deliver high-quality data while maintaining participant safety and protocol compliance. At the same time, healthcare organizations face staffing shortages, financial pressures, and growing operational complexity across research programs.
Many organizations focus heavily on traditional measures of research success, such as study volume, sponsor relationships, or regulatory compliance. While these areas remain critical, operational performance often depends on factors that receive less attention during program planning and oversight.
Clinical research operations focus on the people, processes, systems, and oversight activities that support the planning, conduct, compliance, and administration of clinical research studies across their lifecycle. Interruptions in operations can lead to problems throughout the study. For example, delays in study activation, nominal investigator engagement, enrollment shortfalls, and resource constraints can significantly impact research productivity and operational and financial sustainability.
Clinical research operations challenges often result from small inefficiencies that compound throughout the study lifecycle. Organizations seeking to improve research performance should focus on identifying and addressing these operational barriers before they become larger obstacles to success.
Even well-established clinical research programs encounter operational inefficiencies that limit performance. The following five opportunities highlight common areas where organizations can strengthen clinical research operations to improve study execution and enhance overall program effectiveness.
Five Overlooked Opportunities to Improve Clinical Research Operations
Organizations can improve clinical research operations by focusing on principal investigator engagement, participant recruitment, ancillary-service coordination, study start-up processes, and staffing resilience.
1. Principal Investigator Engagement
Why This Matters
Principal investigator (PI) engagement is a critical factor in clinical trial success and in the fluidity of clinical research operations. Effective PIs do more than serve as the study lead; they actively support recruitment, provide ongoing oversight, and remain engaged throughout the study lifecycle. Their involvement can improve enrollment performance, participant retention, protocol compliance, data integrity, and patient safety.
Where Breakdowns Occur
Many organizations assume that assigning a PI to a protocol is sufficient. In practice, some investigators have limited involvement after study activation, relying heavily on research staff to manage day-to-day activities. Sub-investigators may be even less engaged, particularly when they are unfamiliar with protocol requirements or are only involved when the PI is unavailable.
Without active investigator participation, studies may experience slower enrollment, increased protocol deviations, delayed decision-making, inconsistent oversight, and reduced accountability for trial performance.
How to Address the Opportunity
Establish clear expectations for investigator involvement before study initiation and monitor throughout trial execution. Performance discussions should routinely address recruitment progress, participant retention, protocol compliance, and operational challenges. Organizations may also deploy investigator education and engagement strategies to ensure both principal investigators and sub-investigators understand their responsibilities and remain actively involved throughout the study lifecycle.
Expectations should also clearly distinguish the PI’s overall oversight responsibilities from activities delegated to sub-investigators. Each investigator should be adequately trained and prepared to fulfill their assigned role.
2. Recruitment and Participant Enrollment
Why This Matters
Participant recruitment is an aspect of clinical research operations that is often the deciding factor in whether a study succeeds or falls short of its objectives. Published research highlights the persistent difficulty many studies face in meeting enrollment goals, underscoring the importance of effective recruitment and retention strategies.[1]
Where Breakdowns Occur
Enrollment challenges often begin with insufficient planning. Organizations may lack clearly defined participant identification strategies, robust prescreening processes, or realistic enrollment forecasts. Referral pathways are frequently underdeveloped, and providers outside the study team may have limited awareness of active recruiting opportunities.
Participant education is another commonly overlooked area. Potential participants may not fully understand study expectations, resulting in lower enrollment rates or increased withdrawals after participation begins. Inadequate reimbursement structures, limited outreach efforts, and competition from other studies can further reduce enrollment performance. Referral leakage to competing organizations may also prevent otherwise eligible participants from enrolling.
Participant burden can also influence enrollment and retention. Factors such as travel requirements, visit frequency, scheduling constraints, language barriers, health literacy, and other logistical challenges may discourage participation or contribute to study withdrawals if not proactively addressed.
How to Address the Opportunity
Develop structured recruitment strategies before study activation. These strategies should include clearly defined eligibility criteria, systematic prescreening processes, participant education materials, outreach campaigns, referral pathways, and enrollment forecasting metrics.
Organizations should also monitor enrollment performance regularly and compare actual enrollment against forecasted targets. Dedicated investigator and departmental meetings can provide opportunities to review recruiting studies, identify barriers, and share enrollment performance data among peers. This transparency can increase physician engagement, stimulate referrals, and reinforce accountability for recruitment success. Participant retention efforts, including positive participant experiences and appropriate stipends or reimbursements, should also remain a priority throughout study participation.
3. Ancillary Service Buy-In
Why This Matters
Successful clinical research operations depend on more than the study team alone. Ancillary services, including laboratory, imaging, pharmacy, scheduling, registration, and revenue cycle functions, play a critical role in study activation and execution. Without early engagement and alignment from these groups at the outset, organizations often experience avoidable delays and operational disruptions.
Where Breakdowns Occur
Ancillary departments are frequently engaged too late in the feasibility or study start-up process. As a result, research teams may discover only after study selection that critical support services lack the capacity, expertise, equipment, or willingness to support protocol requirements.
These late discoveries can significantly delay activation timelines and, in some cases, prevent studies from moving forward altogether. Organizations may also struggle with inconsistent responsiveness, unclear service expectations, competing departmental priorities, and a lack of formal escalation pathways when issues arise.
How to Address the Opportunity
Incorporate a formal ancillary services assessment into the study feasibility process and involve ancillary stakeholders early during protocol reviews and operational planning. Operational capabilities, anticipated workloads, required turnaround times, and resource commitments should be discussed before a study is selected or initiated. Organizations should also validate that ancillary departments have the necessary capacity, expertise, equipment, and operational support required to meet protocol-specific requirements or have identified an alternative option before committing to study participation.
Formal service expectations, defined communication pathways, and established escalation processes will help ensure accountability and improve coordination across departments. Early engagement can help prevent avoidable delays and identify operational limitations before they become barriers to study success.
4. Study Start-Up Timelines
Why This Matters
Every day spent in study start-up and planning is a day lost for participant enrollment, site revenue, and research productivity. Although study start-up processes frequently involve multiple stakeholders and regulatory requirements, excessive planning timelines remain one of the most common operational challenges affecting research programs.
Where Breakdowns Occur
Organizations often lack visibility into the full study activation process and associated dependencies. Activities that could be performed simultaneously are frequently completed sequentially, resulting in unnecessary delays.
Contract negotiations, coverage analyses, budget development, ancillary reviews, committee approvals, and IRB submissions may operate independently with limited coordination. (Read PYA’s related article: Clinical Trial Budget Negotiations: Five Opportunities to Strengthen Lifecycle Financial Viability.)
Research teams may also lack a dedicated intake process to ensure study documents and required information are routed efficiently to the appropriate stakeholders. Similarly, organizations may not have a final checkpoint to confirm that all activation requirements have been completed before enrollment begins.
How to Address the Opportunity
Map the entire study start-up process and identify opportunities to streamline workflows. Clearly defined timeline expectations, centralized intake functions, and structured workflow management will help to improve coordination between stakeholders.
Organizations should also establish accountability for study initiation. Performance should be supported by defined operational metrics, such as study selection-to-contract execution, institutional review board (IRB) approval turnaround times, study activation timelines, and study selection-to-open-to-accrual performance. Monitoring activation metrics, identifying bottlenecks, and continuously evaluating start-up performance can significantly reduce activation timelines and accelerate enrollment opportunities.
5. Staffing and Lack of Cross-Training
Why This Matters
Research programs often rely on a small number of individuals with specialized operational knowledge, creating risks to continuity, scalability, and workforce resilience when key personnel are unavailable. Organizations can mitigate these risks through documented processes, cross-training, and effective knowledge transfer practices.
Where Breakdowns Occur
Organizations often experience disruptions when key personnel take time off, change positions, or leave the organization entirely. Research activities can slow dramatically when critical knowledge resides with a single individual rather than within documented processes and shared organizational expertise.
Staff burnout can further compound these challenges, particularly when employees are responsible for multiple aspects of trial management without adequate support or backup resources.
How to Address the Opportunity
Prioritize cross-training, succession planning, and process standardization. Rather than relying on individuals as the primary source of institutional knowledge, create documented, repeatable operational processes that can be performed consistently by multiple team members.
As programs mature and scale, many organizations adopt centralized research service models with specialized functions and built-in redundancies. Operational efficiency often improves when responsibilities are clearly defined, processes are standardized, and multiple team members are trained to provide coverage for critical functions.
Moving from Process to Performance
Successful clinical research programs are not defined solely by the number of studies they conduct. They are also defined by how efficiently and consistently they execute research across the study lifecycle. Organizations that focus on operational aspects including investigator engagement, enrollment performance, ancillary service integration, activation efficiency, and workforce resiliency are often better positioned to improve study outcomes, strengthen sponsor relationships, increase participant access to research, and support long-term program growth. These efforts are most effective when supported by consistent operational metrics that provide leadership visibility into activation timelines, enrollment performance, participant retention, staffing capacity, and recurring workflow bottlenecks.
By addressing these commonly overlooked operational opportunities, healthcare organizations can improve research performance, reduce inefficiencies, and create a stronger foundation for sustainable clinical research success.
For more than 40 years, PYA has helped our clients focus on all operational aspects of clinical research programs to support long-term success.
Learn more!
Read PYA’s related article, Research Compliance in Today’s Healthcare Environment: Five Compliance Challenges and How to Address Them.
Learn about budget negotiations in our related article, Clinical Trial Budget Negotiations: Five Opportunities to Strengthen Lifecycle Financial Viability.
Download PYA’s helpful resource: Building and Sustaining Research Compliance Programs.
Learn about PYA’s Clinical Research Administration Office and our Healthcare Advisory Services.
[1] Carlisle B, Kimmelman J, Ramsay T, MacKinnon N. Unsuccessful trial accrual and human subjects protections: An empirical analysis of recently closed trials. Clinical Trials. Available at: PubMed Central Article
